Speciality chemicals group DSM on Tuesday reported preliminary, unaudited results showing operational profit was up 30% in the fourth quarter and up 20% over the whole of 2013.

Operational profit reached €316m in Q4 compared with €243m in the year earlier period. The company said earlier it expected operating profit over the whole of 2013 to reach just under €1.35bn. Preliminary figures show a profit of €1.31bn compared with €1.1bn for 2012.

In Q4, all clusters delivered a solid performance despite negative exchange rate effects. However, the company’s nutrition division, which includes dietary supplements and fish oil based Omega 3, showed moderate results due to the additional problem market weakness.

‘We are and remain firmly on track to deliver on our strategy and to create sustainable value with all our clusters,’ CEO Feike Sijbesma said in a statement.

Final audited results will be published on February 26.